Emails from Hunter Biden’s notorious laptop reveal that the first son helped secure millions of dollars for a DoD contractor – Metabiota – which specializes in researching pandemic-causing diseases that could be used as bioweapons, according to the Daily Mail, which obtained Hunter’s emails.
Moscow’s claim that Hunter Biden helped finance a US military ‘bioweapons’ research program in Ukraine is at least partially true, according to new emails obtained exclusively by DailyMail.com.
The commander of the Russian Nuclear, Biological and Chemical Protection Forces, claimed there was a ‘scheme of interaction between US government agencies and Ukrainian biological objects’ and pointed to the ‘financing of such activities by structures close to the current US leadership, in particular the investment fund Rosemont Seneca, which is headed by Hunter Biden.’ -Daily Mail
Hunter also appears to have introduced Metabiota to Burisma for a “science project,” ostensibly involving biosecurity labs in Ukraine.
On its face, Metabiota appears to be a simple medical data company – however a 2014 email from its Vice President to Hunter described how they could ‘assert Ukraine’s cultural and economic independence from Russia’ – an odd goal for a biotech firm at the time Hunter’s Dad was US point-man for Ukraine’s ‘reconstruction’ involving the Obama administration.
Emails and defense contract data reviewed by DailyMail.com suggest that Hunter had a prominent role in making sure Metabiota was able to conduct its pathogen research just a few hundred miles from the border with Russia.
The project turned into a national security liability for Ukraine when Russian forces invaded the country last month. -Daily Mail
Digging deeper, we find that Metabiota was working under Black & Veatch – a US defense contractor tied to US intelligence, which built the Ukraine labs that analyzed bioweapons and deadly diseases.
Earlier this month US officials warned congress that ‘Russian forces may be seeking to gain control’ of these ‘biological research facilities’, prompting fears that deadly and even engineered pathogens could fall into Russian hands.
Hunter and his colleagues at his investment firm Rosemont Seneca Technology Partners (RSTP) routinely raised millions of dollars for technology companies, hoping the firms would take off and make them all fortunes.
Metabiota was one of those firms. Emails between Hunter and his colleagues excitedly discuss how the company’s monitoring of medical data could become an essential tool for governments and companies looking to spot outbreaks of infectious diseases. -Daily Mail
Hunter and pals invested $500,000 in Metabiota via Rosemont Seneca Technology Partners – and raised several million through various investment firms, including Goldman Sachs.
In Ukraine, the younger Biden was more intimately involved in Metabiota’s operations – which he bragged about in pitches to investors. Hunter and his partner Eric Schwerin even discussed housing Metabiota in their office space, April 2014 emails reveal.
That same month, Metabiota VP Mary Guttieri wrote Hunter to wax eloquent on how the company could “assert Ukraine’s cultural and economic independence from Russia.”
Read the rest of the report here…
by Tyler Durden
Join: 👉 https://t.me/acnewspatriots
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of AC.NEWS
Disclaimer: This article may contain statements that reflect the opinion of the author. The contents of this article are of sole responsibility of the author(s). AC.News will not be responsible for any inaccurate or incorrect statement in this article www.ac.news websites contain copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available to our readers under the provisions of “fair use” in an effort to advance a better understanding of political, health, economic and social issues. The material on this site is distributed without profit to those who have expressed a prior interest in receiving it for research and educational purposes. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner. Reprinting this article: Non-commercial use OK. If you wish to use copyrighted material for purposes other than “fair use” you must request permission from the copyright owner.
Disclaimer: The information and opinions shared are for informational purposes only including, but not limited to, text, graphics, images and other material are not intended as medical advice or instruction. Nothing mentioned is intended to be a substitute for professional medical advice, diagnosis or treatment.
Discussion about this post